Q2 2019 Biotec Pharmacon ASA Earnings Call Transcript
¸ -
Good morning, everybody. Good morning to the shareholders here in Oslo. And good morning to everybody who is listening on the webcast here today. Also, I'd like to introduce CFO, Børge Sørvoll, who will be here together with me today to present our second quarter results for Biotec Pharmacon.
The agenda is like it is always. We'll go through some highlights for Q2. We'll spend some time with our ArcticZymes business. We'll spend some time talking about the BetaGlucan business. Then Børge will come on the podium and will run you through the financials, and I will come back and discuss the outlook for 2019. Questions, of course, are always welcome, and we will see if we can answer them. We also have possibilities to answer your questions on the Web. So if anybody is listening in and having a question to ask, we have facilities so we can take those questions on the Web and answer them here.
This is a slide that we show every time we are presenting ourselves. It's just the basis of what we are and why do we have these 2
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
